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Identity 
Note: it is likely that breakpoints are heterogeneous, 
with 2 distinct entities: t(4;12)(q11-12;p13) in ANLL, 
and t(4;12)(q13-21;p13) in ALL to be delineated.  
Clinics and pathology 
Disease 
ANLL and therapy related AL cases with t(4;12)(q11-
12;p13); B-cell ALL cases seem to have a more distal 
breakpoint in 4q13 or 21. 
Phenotype / cell stem origin 
ANLL cases: M0, M1, and other subtypes; often CD7+; 
a stem cell may be involved; ALL cases are CD10+. 
Epidemiology 
Only 13 available cases: 9 ANLL and 4 ALL; so far, 
ANLL cases with a proximal breakpoint in 4q11 or 12 
are adult cases (43-77 yrs), and ALL cases are children 
cases (3-14 yrs); balanced sex ratio. 
Prognosis 
Adult cases: response to therapy is poor and median 









None in 5/12 cases (all 5 cases are ANLL); del(6q) has 
recurrently been found in ALL; -7 would be recurrent if 
only 1 entity exists; the karyotype in ALL cases can be 
complex. 
Genes involved and Proteins 
ETV6 
Location: 12p13 
DNA / RNA 
9 exons; alternate splicing. 
Protein 
Contains a Helix-Loop-Helix and ETS DNA binding 
domains; wide expression; nuclear localisation; ETS-
related transcription factor. 
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